Pregnancy
category N/A Legal status Never marketed PubChem CID 5362422 | ATC code none CAS Number 130370-60-4 Molar mass 477.64 g/mol | |
 | ||
Routes of
administration Injection into pleural space or abdomen | ||
Batimastat (INN/USAN, codenamed BB-94) is an anticancer drug that belongs to the family of drugs called angiogenesis inhibitors. It acts as a matrix metalloproteinase inhibitor (MMPI) by mimicking natural MMPI peptides.
Batimastat was the first MMPI that went into clinical trials. First results of a Phase I trial appeared in 1994. The drug reached Phase III but was never marketed; mainly because it couldn't be administered orally (as opposed to the newer and chemically similar MMPI marimastat), and injection into the peritoneum caused peritonitis.
How to pronounce batimastat
References
Batimastat Wikipedia(Text) CC BY-SA